Insights Library

Review our latest comprehensive white papers, informative webinars, and illuminating case studies.

SR-Pharmacokinetics-Hero-1

White Papers

Learn more about our expertise

Efficient Drug Discovery Powered by High Accuracy A.I. Models
Download our white paper to discover how Southern Research accelerates drug discovery through innovative practices.

 

Ensuring the Safety of Novel Viral Vector Platforms
Download our white paper to learn how we assess neurovirulence and neurotoxicity for responsible development of viral-based medicines.

 

Mission Ready: Prepared to Respond to the Next Pandemic
Download our white paper to learn how Southern Research provides expertise in developing new treatments against seasonal influenza.

CASE STUDY: Southern Research Enables Fortune 500 Pharmaceutical Company to Rapidly File IND Application

A Fortune 500 pharmaceutical company approached SR about testing a prophylactic molecule in reducing or preventing influenza infection in a ferret model. Download the case study here to learn more.

CASE STUDY: Southern Research Successfully Tests BioNTech MPXV Vaccine in NHPs

German biotechnology company BioNTech SE approached Southern Research to test the efficacy of their prophylactic (mRNA vaccine) against highly pathogenic MPXV Zaire strain in non-human primates (NHPs). Download the case study here to learn more.

CASE STUDY: Southern Research Enables Accelerated Timeline for Pharmaceutical Company’s Therapeutics for Monkeypox Virus

A medium-sized pharmaceutical company approached Southern Research (SR) to test the efficacy of their therapeutic molecules against highly pathogenic MPXV, Zaire strain in non-human primates (NHPs). Download the case study here to learn more.

SR-Oncology-Webinar-Graphic-Image-1

Oncology Webinar

The tumor immune microenvironment (TIME) plays a major role in tumor progression, therapy response, and ultimate prognosis. Therefore, key cells, pathways, and proteins within the TIME are being evaluated as targets for new cancer drugs. Watch as Dr. Rebecca Boohaker, our Director of Oncology, highlights progress in three drug discovery initiatives that use this interdisciplinary approach to target immune suppression in the TIME.

Watch Now

Harry Ledebur, Ph.D.

Chief Operating Officer

Corinne E.
Augelli-Szafran, Ph.D.

Vice President of Scientific Platforms

Donghui Bao, Ph.D.

Scientist III

Jennifer Pickens, Ph.D.

Director of Infectious Disease Research

Joseph Randall, Ph.D.

Director of Toxicology

Rebecca Boohaker, Ph.D.

Director of Oncology

Paige N. Vinson, Ph.D.

Director, High-Throughput Screening

Sixue Zhang, Ph.D.

Head of A.I. Drug Discovery

Southern Research News

Southern Research awards biotech funds, bringing new jobs and business to Alabama

Southern Research awards biotech funds, bringing new jobs and business to Alabama

June 28, 2024

June 27, 2024, Birmingham, Ala – Southern Research has awarded more than $2.7 million in funds to eight biotech companies through a fund established as a result of the Innovate Alabama Tax Credit.
Read More
Southern Research Selects Chief Operating Officer

Southern Research Selects Chief Operating Officer

May 9, 2024

May 8, 2024 Birmingham, Ala. – Harry C. Ledebur, Jr., Ph.D., is joining Southern Research as Chief Operating Officer, bringing to the role more than 25 years of experience across the pharmaceutical, biotechnology, and contract-research industry. In his new position at Southern ...
Read More
Southern Research Awarded Grant to Develop Novel Antidotes for Arsenical Poisoning

Southern Research Awarded Grant to Develop Novel Antidotes for Arsenical Poisoning

April 11, 2024

Project Aims to Deliver Safer and More Effective Treatments for Cutaneous Injuries Southern Research is pleased to announce the award of a UG3/UH3 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (N...
Read More

© 2024 Southern Research. All rights reserved.